The small heat shock proteins, especially HspB4 and HspB5 are promising protectants in neurodegenerative diseases

Publication date: May 2018 Source:Neurochemistry International, Volume 115 Author(s): Zhihui Zhu, Georg Reiser Small heat shock proteins (sHsps) are a group of proteins with molecular mass between 12 and 43 kDa. Currently, 11 members of this family have been classified, namely HspB1 to HspB11. HspB1, HspB2, HspB5, HspB6, HspB7, and HspB8, which are expressed in brain have been observed to be related to the pathology of neurodegenerative diseases, including Parkinson's, Alzheimer's, Alexander's disease, multiple sclerosis, and human immunodeficiency virus-associated dementia. Specifically, sHsps interact with misfolding and damaging protein aggregates, like Glial fibrillary acidic protein in AxD, β-amyloid peptides aggregates in Alzheimer's disease, Superoxide dismutase 1 in Amyotrophic lateral sclerosis and cytosine-adenine-guanine/polyglutamine (CAG/PolyQ) in Huntington's disease, Spinocerebellar ataxia type 3, Spinal-bulbar muscular atrophy, to reduce the toxicity or increase the clearance of these protein aggregates. The degree of HspB4 expression in brain is still debated. For neuroprotective mechanisms, sHsps attenuate mitochondrial dysfunctions, reduce accumulation of misfolded proteins, block oxidative/nitrosative stress, and minimize neuronal apoptosis and neuroinflammation, which are molecular mechanisms commonly accepted to mirror the progression and development of neurodegenerative diseases. The increasing incidence of the neurodegenerative diseases enhance...
Source: Neurochemistry International - Category: Neuroscience Source Type: research

Related Links:

Juvenile systemic lupus erythematosus (jSLE), mixed connective tissue disease (jMCTD), and Sj ögren syndrome (jSS) are systemic autoimmune and inflammatory disorders with distinct patterns of organ involvement. All are characterized by autoantibody formation, with antinuclear (ANA) and anti-double-stranded DNA common in jSLE, ANA with high-titer ribonucleoprotein antibody in jMCTD, and Sjö gren syndrome A and Sjögren syndrome B antibodies + ANA in jSS. Recognition, monitoring, and management for primary care providers are discussed, focusing on the role of primary physicians in recognizing and helping mainta...
Source: Pediatric Clinics of North America - Category: Pediatrics Authors: Source Type: research
The juvenile idiopathic inflammatory myopathies (JIIM) are a group of rare, chronic, autoimmune illnesses that affect muscle and, to a lesser extent, skin. The presence of new-onset weakness and, in juvenile dermatomyositis, typical rahes, should lead to consideration of these diagnoses. Careful evaluation to exclude alternative diagnoses is needed. Investigations include a variety of blood tests, imaging, and possibly muscle biopsy. Validated clinical assessments are available for monitoring. Standard treatment includes corticosteroids and methotrexate and often extends beyond 1  year. Outcomes are generally good, bu...
Source: Pediatric Clinics of North America - Category: Pediatrics Authors: Source Type: research
Systemic juvenile idiopathic arthritis (sJIA) is a distinctive subtype of juvenile idiopathic arthritis, characterized by fever and arthritis, often accompanied by rash, sometimes by generalized lymphadenopathy, hepatosplenomegaly, and serositis. The diagnosis requires adequate exclusion of infectious, oncologic, autoimmune, and autoinflammatory diseases. Macrophage activation syndrome, a serious and potentially fatal complication of sJIA, requires prompt evaluation and treatment. Newer biologic agents, particularly interleukin-1 and interleukin-6 inhibitors, are highly effective and have transformed the treatment approach...
Source: Pediatric Clinics of North America - Category: Pediatrics Authors: Source Type: research
ConclusionOur studies demonstrate that VPA exerts neuroprotective effects in a rat model of 6-OHDA-induced Parkinson's disease (PD), likely in part by up-regulation BDNF.
Source: Journal of the Formosan Medical Association - Category: General Medicine Source Type: research
Authors: Chen C, Xie Z, Shen Y, Xia SF Abstract It is widely accepted that thyroid hormones (THs), secreted from the thyroid, play important roles in energy metabolism. It is also known that THs also alter the functioning of other endocrine glands; however, their effects on pancreatic function have not yet been reviewed. One of the main functions of the pancreas is insulin secretion, which is altered in diabetes. Diabetes, therefore, could be related to thyroid dysfunction. Earlier research on this subject focused on TH regulation of pancreas function (such as insulin secretion) or on insulin function through TH-me...
Source: International Journal of Endocrinology - Category: Endocrinology Tags: Int J Endocrinol Source Type: research
Alzheimer's and Other Dementias
Source: Clinics in Geriatric Medicine - Category: Geriatrics Source Type: research
This article describes the epidemiology of delirium and dementia in the ED and how it affects clinical care and patient outcomes. Screening for delirium and dementia in the context of the busy ED environment, as well as their diagnostic evaluation and management, is discussed.
Source: Clinics in Geriatric Medicine - Category: Geriatrics Authors: Source Type: research
Researchers have found that changes in PET scans of military personnel with...Read more on AuntMinnie.comRelated Reading: Did PET scan confirm CTE in living NFL player? MRI shows promise in diagnosing CTE in living patients FDDNP-PET gives insight into brain trauma of NFL players FDDNP-PET shows toll of concussions on retired NFL players FDDNP-PET helps predict Alzheimer's progression
Source: Headlines - Category: Radiology Source Type: news
Early intervention to treat sleep disorders such as obstructive sleep apnea may help prevent or delay Alzheimer’s disease.
Source: ENT Today - Category: ENT & OMF Authors: Tags: Online Exclusives Practice Focus Sleep Medicine alzheimer's disease Source Type: research
Publication date: Available online 18 July 2018Source: Life SciencesAuthor(s): Monika M. GolasAbstractThe loss of gamma-aminobutyric acid (GABA)-ergic medium spiny neurons (MSNs) in the striatum is the hallmark of Huntington disease (HD), an incurable neurodegenerative disorder characterized by progressive motor, psychiatric, and cognitive symptoms. Transplantation of MSNs or their precursors represents a promising treatment strategy for HD. In initial clinical trials in which HD patients received fetal neurografts directly into the striatum without a pretransplant cell-differentiation step, some patients exhibited tempora...
Source: Life Sciences - Category: Biology Source Type: research
More News: ALS | Alzheimer's | Ataxia | Autoimmune Disease | Brain | Dementia | Huntington's Disease | Mitochondrial Disease | Multiple Sclerosis | Neurology | Neuroscience | Parkinson's Disease | Pathology | Toxicology